Company Monitoring Page for Pfizer

latest headlines for company on cafepharma

Pfizer launches biosimilars to Roche’s ‘big three’ cancer drugs in US
Pharmaforum
Fri, 01/24/20 - 10:11 am
Tags:
Pfizer, Roche, biosimilars, Avastin, Zirabev, Herceptin, Trazimera, Rituxan, Ruxience
Pfizer to Market Viagra Through Roman's Telehealth Service
Motley Fool
Thu, 01/23/20 - 12:16 pm
Tags:
Pfizer, Roman, Ro, generics, Viagra, erectile dysfunction, telehealth, digital health, Greenstone
GlaxoSmithKline halts Excedrin production over manufacturing stumble
Fierce Pharma
Tue, 01/21/20 - 11:35 am
Tags:
GSK, consumer health, Pfizer, Excederin, drug manufacturing
Pfizer teams up with Insilico to mine data for drug targets
Fierce Biotech
Thu, 01/16/20 - 10:09 am
Tags:
Pfizer, R&D, Insilico, real world evidence, RWE
GSK, Pfizer contradict on the future of consumer health JV — report
Endpoints
Thu, 01/16/20 - 10:03 am
Tags:
GSK, Pfizer, consumer health, JPMHC 2020
Biogen makes another Alzheimer's bet, paying Pfizer $75M for early-phase drug
Fierce Biotech
Mon, 01/13/20 - 10:51 am
Tags:
Biogen, Alzheimer's disease, Pfizer, PF-05251749
Upcoming events – Pfizer's abrocitinib and Myovant's relugolix
EP Vantage
Sat, 01/11/20 - 12:01 am
Tags:
Pfizer, abrocitinib, Dupixent, Sanofi, Myovant, Relugolix, uterine fibroids
Pfizer may look messy post-Upjohn spinoff, but better days could be ahead: analyst
Fierce Pharma
Thu, 01/9/20 - 11:53 pm
Tags:
Pfizer, Upjohn, Mylan, spinoffs, generics
Pfizer and eFFECTOR Ink $507 Million Cancer Deal
BioSpace
Thu, 01/9/20 - 04:09 pm
Tags:
Pfizer, Effector, small molecule drugs, cancer, drug development
A big finish confirms 2019 as a takeover year to remember
EP Vantage
Thu, 01/9/20 - 10:49 am
Tags:
M&A, AbbVie, Allergan, Astellas, Bristol-Myers Squibb, Eli Lilly, Merck, Novartis, Pfizer, Sanofi
Merck KGaA, Pfizer's Bavencio set to seal bladder cancer approval after confirmatory trial scores
Endpoints
Mon, 01/6/20 - 10:16 am
Tags:
Merck KGaA, Pfizer, Bavencio, bladder cancer, FDA
Upcoming events – Karyopharm's myeloma expansion and Pfizer's biz dev news
EP Vantage
Sun, 01/5/20 - 07:10 pm
Tags:
Karyopharm, Xpovio, Multiple Myeloma, Pfizer, Akcea, Ionis Pharmaceuticals, AKCEA-ANGPTL3-Lrx
Homegrown rivals to Pfizer, Merck cash cow vaccines win nods in China
Fierce Pharma
Sun, 01/5/20 - 07:07 pm
Tags:
Pfizer, Merck, Prevnar 13, Gardasil, vaccines, China, Walvax
Corporate and regulatory developments over the Christmas period
EP Vantage
Thu, 01/2/20 - 11:39 pm
Tags:
Astellas, M&A, Qiagen, AstraZeneca, Bausch Health, BeiGene, Celyad, Immunomedics, Merck, Merck KGaA, Ono Pharmaceutical, Pfizer, Pharming, Xyphos Biosciences
Pfizer, BMS, Gilead, AbbVie and others hike prices on hundreds of meds to ring in 2020
Fierce Pharma
Thu, 01/2/20 - 10:46 am
Tags:
drug pricing, Pfizer, Bristol-Myers Squibb, AbbVie
As Bristol-Myers, Pfizer battle copycat challengers in court, FDA approves generics for blockbuster Eliquis
Endpoints
Thu, 12/26/19 - 01:18 pm
Tags:
Pfizer, Bristol-Myers Squibb, FDA, generics, bloodthinners, Eliquis, Micro Labs, Mylan
Pfizer Strikes JAK Inhibitor Deal Worth Up to $250 Million With Theravance
BioSpace
Mon, 12/23/19 - 11:52 pm
Tags:
Pfizer, Theravance, JAK inhibitors
Pharma's gene and cell therapy ambitions will kick into high gear in 2020—despite some major hurdles
Fierce Pharma
Thu, 12/19/19 - 01:11 pm
Tags:
gene therapy, reimbursement, drug manufacturing, Bristol-Myers Squibb, Pfizer, Biomarin, Sarepta Therapeutics, Gilead Sciences, CAR-T
Exact Sciences Should Benefit from Pfizer’s News Today
Motley Fool
Thu, 12/19/19 - 12:05 am
Tags:
Pfizer, colorectal cancer, EXACT Sciences, FDA, Braftovi, Cologuard
As NASH shifts again, the focus remains on Genfit’s big readout
EP Vantage
Wed, 12/18/19 - 10:53 am
Tags:
NASH, Genfit, elafibranor, Pfizer, Boehringer Ingelheim, Gilead Sciences, Poxel, Takeda, Intercept Pharma

Pages

last 30 twitter posts

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.